Marty Makary
Major Shake-Up: FDA Official Who Examined COVID Vaccines and Antidepressants Ousted
Dr. Tracy Beth Hoeg, an FDA official responsible for overseeing the safety of antidepressants and COVID-19 vaccines, has been let ... Read more
FDA Shakeup: Kyle Diamantas Takes the Helm—What This Means for the Future of the Food Industry
President Trump has appointed Kyle Diamantas as the acting commissioner of the Food and Drug Administration (FDA) following Marty Makary’s ... Read more
Trump’s FDA Chief Exits Amid Controversy with Pharma Giants, Vaping Lobbyists, and Anti-Abortion Activists
Makary Resigns from FDA Amid Controversy Dr. Marty Makary is stepping down as head of the FDA after just 13 ... Read more
FDA Unveils Limited Evidence on Drug Promoted by Trump for Autism Treatment: What You Need to Know
Recently, the FDA approved leucovorin, a generic medication, for a rare brain disorder. However, this decision has sparked some controversy, ... Read more
MAHA’s Major Win: Target Eliminates Synthetic Colors from Your Favorite Breakfast Foods!
Target is taking a bold step in the grocery aisle. The retail giant announced it will eliminate synthetic colors from ... Read more
Unpacking the Controversy: Key Legal Questions Surrounding the FDA’s New Fast-Track Drug Approval Program
There’s growing concern within the FDA about a new program aimed at speeding up drug reviews. This initiative, backed by ... Read more
Breaking News: FDA Lifts Long-Standing Warning on Hormone Therapy for Menopause—What It Means for You!
Recently, the FDA made a notable change regarding hormone-based treatments for menopause. The agency announced that over 20 hormone medications, ... Read more
US Health Officials Target Kratom Products Amid Rising Complaints from the Supplement Industry
Concerns Over New Opioid Ingredient in Energy Drinks U.S. health officials are raising alarms about a dangerous ingredient found in ... Read more
Sarepta Therapeutics Faces 40% Stock Drop: What This Means for the Future of Gene Therapy
Shares of Sarepta Therapeutics tumbled over 30% recently, raising concerns about the future of its gene therapy treatment, Elevidys. The ... Read more
